• To compare postoperative sequential RT and chemotherapy to RT alone in adults with newly diagnosed AO or mixed AOA. (cochrane.org)
  • 16 patients (76%) received postoperative adjuvant radiotherapy. (smw.ch)
  • In order to achieve a more effec- were recommended postoperative radiation and adjuvant tive and individualised chemotherapeutic treatment of breast chemotherapy. (lu.se)
  • We excluded no specific chemotherapy regimens. (cochrane.org)
  • as monotherapy for the treatment of those patients who have received at least two chemotherapy regimens for their metastatic disease. (who.int)
  • For chemotherapy, two-drug cytotoxic regimens that include a platinum agent are generally preferred for first-line therapy. (medscape.com)
  • Two recent randomized trials have suggested benefit of neoadjuvant chemoradiotherapy over upfront surgery, both including single-agent chemotherapy regimens. (nih.gov)
  • The PREOPANC-2 trial directly compares two neoadjuvant regimens for patients with resectable and borderline resectable pancreatic cancer. (nih.gov)
  • Chemotherapy regimens containing anthracyclines, ifosfamide, or taxanes have been reported. (medscape.com)
  • For description of chemotherapy and chemoradiotherapy regimens, see Gastric Cancer Treatment Protocols . (medscape.com)
  • The immunotherapy has already been approved for several other NSCLC indications , including as first-line treatment along with pemetrexed and platinum chemotherapy for patients with metastatic nonsquamous NSCLC without EGFR or ALK genomic tumor aberrations. (medscape.com)
  • For secondary (also called metastatic or advanced) breast cancer, chemotherapy can often be prescribed as a single drug. (owise.uk)
  • citation needed] This systemic therapy (chemotherapy, immunotherapy or hormone therapy) or radiation therapy is commonly used in cancers that are locally advanced, and clinicians plan an operation at a later stage, such as pancreatic cancer. (wikipedia.org)
  • When chemotherapy is used at the beginning of your cancer treatment and before starting radiation therapy , it's referred to as induction chemotherapy. (healthline.com)
  • The goal of induction chemotherapy is to shrink tumors before beginning radiation therapy. (healthline.com)
  • Concurrent chemotherapy radiation therapy is when chemotherapy and radiation therapy are performed together. (healthline.com)
  • Induction chemotherapy is the type used before radiation therapy. (healthline.com)
  • However, induction chemotherapy should be used when chemotherapy occurs before radiation therapy. (healthline.com)
  • The goal of induction chemotherapy is to reduce tumor size to make it easier for radiation therapy to get rid of cancer cells and to reduce the chances of cancer spreading to distant parts of your body. (healthline.com)
  • Induction chemotherapy is used as a first-line treatment for cancer to prepare you for radiation therapy. (healthline.com)
  • Clinical trials have found that induction chemotherapy seems to be at least equally as effective as chemotherapy and radiation therapy together for treating head and neck cancers. (healthline.com)
  • A 2016 study found evidence that patients with stage 2 or stage 3 non-small cell lung cancer may benefit from induction chemotherapy before concurrent chemotherapy and radiation therapy. (healthline.com)
  • Radiation therapy is often given with chemotherapy. (medscape.com)
  • Finally, neoadjuvant therapy consisting of Capecitabine plus radiation therapy, for locally advanced rectal cancer was analysed. (wjgnet.com)
  • The goal of definitive radiotherapy is to eradicate intra-thoracic disease while respecting the radiation tolerance of nearby normal structures by minimizing the dose to such structures. (cancernetwork.com)
  • 3-6] Most innovative techniques have focused on conformal treatment delivery with computer assisted three-dimensional therapy planning and, in some cases, intensity-modulated radiotherapy in which more complex treatment planning and delivery can allow the radiation oncologist to have better control of doses to healthy tissues. (cancernetwork.com)
  • In a retrospective chart review, patients who received multimodality treatment (any combination of surgery, radiation therapy, and chemotherapy) had an estimated median survival of 36.5 months compared with 14.1 months for patients treated with surgery, radiation therapy, or chemotherapy only (P=0.05). (medscape.com)
  • Postsurgical radiation and chemotherapy have not proven consistently beneficial. (medscape.com)
  • However, adjuvant radiation or chemotherapy can be beneficial in ameliorating symptoms and improving quality of life. (medscape.com)
  • The improved treatment outcome has been attributed to earlier detection and institution of treatment, improved staging accuracy with the application of MRI, improved treatment planning with CT, improved dose distribution with intensity-modulated radiation therapy, and the use of chemotherapy though local failure is still a major hindrance to successful treatment. (hindawi.com)
  • Previously, limb STS were treated by amputation until 1982 when a randomised controlled trial that showed no benefit regarding overall survival (OS) when amputation was compared to limb-sparing resection plus adjuvant radiation therapy [ 4 ]. (jcancer.org)
  • This editorial highlights the relevance of interfering in cancer cell progression through the pharmacological manipulation on the cell metabolism of cyclic nucleotides such as cAMP, and on the intracellular Ca2+ signaling, which may avail the reduction of toxic effects promoted by chemotherapy, radiotherapy and immunotherapy, thus decreasing the incidence of interruption in antitumoral treatment. (researchgate.net)
  • The US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda) in the adjuvant setting for patients with stage IB-IIIA non-small cell lung cancer (NSCLC) following resection and platinum-based chemotherapy. (medscape.com)
  • Among the 1010 patients who received adjuvant platinum-based chemotherapy, the median DFS was 58.7 months in the pembrolizumab arm (n = 506) and 34.9 months in the placebo arm (hazard ratio, 0.73). (medscape.com)
  • As reported in The New England Journal of Medicine by Forde et al, the phase III CheckMate 816 trial has shown improved pathologic complete response rate and event-free survival with the addition of nivolumab to platinum-based chemotherapy in the neoadjuvant treatment of resectable non-small cell lung cancer (NSCLC). (ascopost.com)
  • Patients had not received neoadjuvant radiotherapy or chemotherapy. (medscape.com)
  • In an exploratory subgroup analysis of the 167 patients who did not receive adjuvant chemotherapy, the DFS hazard ratio was 1.25. (medscape.com)
  • To assess long-term outcomes and toxicity of adjuvant radiotherapy in the post-surgical management of patients with resected high-grade skeletal osteosarcomas. (cun.es)
  • Seventy-two patients with primary resected osteosarcomas underwent adjuvant radiotherapy after neoadjuvant chemotherapy from December 1984 to December 2008. (cun.es)
  • A multimodal radiotherapy-containing approach is a well-tolerated component of treatment for patients with osteosarcomas undergoing programed resection, allowing low toxicity rates while maintaining high local control rates. (cun.es)
  • The study aimed to compare the efficacy and safety of androgen deprivation therapy (ADT) with abiraterone or docetaxel versus ADT alone as neoadjuvant therapy in patients with very-high-risk localized prostate cancer. (frontiersin.org)
  • Factors associated with less satisfied patients regarding skin sensitivity in the operated breast were an excision of ≥20% of preoperative breast volume, a BMI of 25-30 kg/m 2 , axillary clearance, and radiotherapy. (springer.com)
  • In February 1998 she joined the CRCTU as a Trial Coordinator coordinating a national, multicentre, phase III, trial called SECRAB which was designed to determine the optimal sequence of chemotherapy and radiotherapy in patients with early breast cancer. (birmingham.ac.uk)
  • Prior chemotherapy must have included at least an anthracycline and a taxane unless patients are unsuitable for these treatments. (who.int)
  • Triple-negative breast cancer (TNBC) patients with residual disease (RD) after neoadjuvant systemic therapy (NAST) are at high risk for recurrence. (nature.com)
  • Biomarkers to risk-stratify patients with RD could help individualize adjuvant therapy and inform future adjuvant therapy trials. (nature.com)
  • The addition of adjuvant chemotherapy with capecitabine in TNBC patients with residual disease has been shown to improve outcomes, though many patients still experience disease recurrence despite the addition of adjuvant chemotherapy, and this approach may lead to overtreatment in some patients since not all patients with residual disease experience a recurrence 4 , 5 . (nature.com)
  • Thus, tools to further stratify the risk of recurrence in patients with residual disease can optimize the utilization of available adjuvant therapy and improve the efficiency of clinical trials investigating novel agents in this setting. (nature.com)
  • Most TNBC patients with residual disease will receive adjuvant radiotherapy and/or chemotherapy, and recent work has shown that adjuvant therapy may influence ctDNA status in patients with residual disease 11 . (nature.com)
  • In the open-label international trial, 358 patients with stage IB to IIIA resectable disease were randomly assigned between March 2017 and November 2019 to receive neoadjuvant treatment with nivolumab at 360 mg plus platinum-doublet chemotherapy (n = 179) or platinum-doublet chemotherapy alone (n = 179) every 3 weeks for three cycles before definitive surgery. (ascopost.com)
  • Patients in both groups could receive up to four cycles of adjuvant chemotherapy, radiotherapy, or both. (ascopost.com)
  • Adjuvant chemotherapy was received by 11.9% of the patients in the nivolumab group and 22.2% of the control group. (ascopost.com)
  • The investigators concluded: "In patients with resectable NSCLC, neoadjuvant nivolumab plus chemotherapy resulted in significantly longer event-free survival and a higher percentage of patients with a pathological complete response than chemotherapy alone. (ascopost.com)
  • Radiotherapy and chemotherapy are an important adjuvant method for these patients. (spandidos-publications.com)
  • Patients from the intervention groups of two separate randomized controlled trials were included: patients with breast cancer receiving neoadjuvant chemotherapy (n=74) and patients with locally advanced prostate cancer receiving treatment with radiotherapy (n=75). (jmir.org)
  • The PREOPANC-2 trial investigates whether neoadjuvant FOLFIRINOX improves OS compared with neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine in resectable and borderline resectable pancreatic cancer patients. (nih.gov)
  • Patients receive 8 cycles of neoadjuvant FOLFIRINOX chemotherapy followed by surgery without adjuvant treatment (arm A), or 3 cycles of neoadjuvant gemcitabine with hypofractionated radiotherapy (36 Gy in 15 fractions) during the second cycle, followed by surgery and 4 cycles of adjuvant gemcitabine (arm B). The primary endpoint is OS by intention-to-treat. (nih.gov)
  • Our study will provide evidence on the neoadjuvant treatment of choice for patients with resectable and borderline resectable pancreatic cancer. (nih.gov)
  • [ 23 ] In a case series of 44 patients with primary right-sided sarcomas, the addition of neoadjuvant chemotherapy increased survival from 9.5 months to 20 months. (medscape.com)
  • For patients with unresectable tumors, treatment with fluoropyrimidine- or taxane-based chemoradiotherapy (category 1 recommendation) or chemotherapy is acceptable. (medscape.com)
  • Patients who had complete response but developed recurrence at the primary site more than 4 months following completion of radical radiotherapy with or without chemotherapy were identified as having a recurrence. (hindawi.com)
  • Some patients received neoadjuvant chemotherapy and/or radiotherapy according to local protocols, while others benefited from primary ILP. (jcancer.org)
  • On average, 114 days elapsed from the time patients had their first symptoms to when they received chemotherapy, and 81% of this time was spent within the primary care system. (bcmj.org)
  • While chemotherapy can be an effective treatment option, it can also be daunting and overwhelming for patients who may not know what to expect during the process. (owise.uk)
  • During chemotherapy, patients commonly receive two or more different drugs. (owise.uk)
  • As a treatment that many cancer patients go through, Consultant Radiotherapist & Oncologist Dr. Shum Weng Yon says that chemotherapy involves the administering of one or more anti-cancer drugs. (mahkotamedical.com)
  • Le protocole utilisé dans le traitement du myélome multiple a été le VMCD-REV à 76,92% avec pour réponse thérapeutique complète chez 6 patients, 3 réponses partielles et 4 en cours de traitement. (bvsalud.org)
  • Adjuvant polychemotherapy (e.g. with 58% to 68%) for patients under the age of 50.1 Besides an cyclophosphamide, methotrexate and 5-fluorouracil (CMF)) or improvement in clinical outcome, these figures indicate that anthracycline-containing regimes, produce substantial reduc- a large proportion of the patients will never recur after the tion in recurrence and mortality. (lu.se)
  • Patients and methods proportion of the patients will recur despite treatment with adjuvant polychemotherapy. (lu.se)
  • Radiotherapy was delivered to ipsilateral axil- cancer patients in the future, it is essential to increase our lary and supraclavicular lymph nodes and the remaining knowledge in mechanisms responsible for drug resistance, breast parenchyma after breast conservation surgery or tho- and to define reliable indicators for response to therapy. (lu.se)
  • BT-ON013 trade name] treatment should only be initiated by a health care provider experienced in the administration of cytotoxic chemotherapy (see section 4.4), and should be administered by a health care provider only. (who.int)
  • The cytotoxic effect of chemotherapy on these healthy cells can commonly result in side effects such as hair loss, changes to nails, mouth sores, diarrhea, nausea and vomiting. (owise.uk)
  • Cancer chemotherapy involves the use of one or more cytotoxic agents to treat cancer. (mahkotamedical.com)
  • Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone? (wjgnet.com)
  • Khan K, Wale A, Brown G, Chau I. Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone? (wjgnet.com)
  • In one case report, preoperative chemotherapy reduced the size of an unresectable undifferentiated cardiac sarcoma, allowing complete resection of residual tumor. (medscape.com)
  • Treatment is surgical resection and chemotherapy for nodal involvement. (msdmanuals.com)
  • Treatment is surgical resection and chemotherapy for nodal. (msdmanuals.com)
  • This combination of chemotherapy and radiotherapy has a special role in tumor down staging and in sphincter preservation for lower rectal tumors. (wjgnet.com)
  • As chemotherapy affects cell division, tumors with high growth fractions (such as acute myelogenous leukemia and the aggressive lymphomas , including Hodgkin's disease ) are more sensitive to chemotherapy, as a larger proportion of the targeted cells are undergoing cell division at any time. (wikidoc.org)
  • After surgery, the participants had to have received radiotherapy alone, chemotherapy alone or radiotherapy plus chemotherapy. (cochrane.org)
  • Grade 3 or 4 treatment-related adverse events occurred in 33.5% of the nivolumab-plus-chemotherapy group vs 36.9% of the chemotherapy-alone group. (ascopost.com)
  • Neoadjuvant therapy is the administration of therapeutic agents before a main treatment. (wikipedia.org)
  • One example is neoadjuvant hormone therapy prior to radical radiotherapy for adenocarcinoma of the prostate. (wikipedia.org)
  • Neoadjuvant therapy aims to reduce the size or extent of the cancer before using radical treatment intervention, thus both making procedures easier and more likely to succeed and reducing the consequences of a more extensive treatment technique, which would be required if the tumor were not reduced in size or extent. (wikipedia.org)
  • Another related concept is that neoadjuvant therapy acts on micrometastatic disease. (wikipedia.org)
  • In some cases, magnetic resonance imaging can predict the response of a patient to neoadjuvant therapy, for example in ovarian cancer. (wikipedia.org)
  • Not everyone is suitable for neoadjuvant therapy because it can be extremely toxic. (wikipedia.org)
  • Compared with ADT alone, neoadjuvant therapy with ADT plus docetaxel or abiraterone could achieve better pathological outcomes (pCR or MRD) for very-high-risk localized prostate cancer. (frontiersin.org)
  • Chemotherapy is a drug therapy that's used to treat many different types of cancer. (healthline.com)
  • Keep reading as we take a look at when induction chemotherapy may be used and how it compares to consolidation therapy and other types of chemotherapy. (healthline.com)
  • During consolidation therapy, chemotherapy drugs are administered in higher doses . (healthline.com)
  • The combination of chemotherapy drugs administered is often similar as during induction therapy. (healthline.com)
  • Acute leukemias are often treated with induction therapy and consolidation chemotherapy once the cancer is in remission. (healthline.com)
  • 2 cm in diameter, as adjuvant therapy following neoadjuvant chemotherapy and surgery (see sections 4.4 and 5.1). (who.int)
  • Neoadjuvant systemic therapy (NAST) is commonly employed in TNBC, and residual disease after NAST is associated with a high risk of recurrence and death 2 , 3 . (nature.com)
  • The approval is the first for neoadjuvant therapy in early-stage NSCLC. (ascopost.com)
  • The benefit of nivolumab was maintained in analysis adjusted for optional receipt of adjuvant therapy (HR = 0.65, 95% CI = 0.47-0.90). (ascopost.com)
  • Adjuvant Therapy - A type of therapy that is used to kill the cancer cells that got left behind post surgery. (newhopemedicalcenter.com)
  • Complete surgical excision remains the mainstay of therapy for primary cardiac sarcoma, followed by radiotherapy with or without sequential chemotherapy. (medscape.com)
  • Medical history of chemotherapy or endocrine therapy for breast cancer, or with treatment history of radiotherapy. (astrazenecaclinicaltrials.com)
  • The targeted-therapy revolution has arrived, but the principles and limitations of chemotherapy discovered by the early researchers still apply. (wikidoc.org)
  • Neoadjuvant therapy may be recommended to people with HER2-positive, triple negative, breast cancer (BRCA) gene-positive, high risk or inflammatory breast cancer. (owise.uk)
  • Known as adjuvant therapy, chemotherapy can be used after other treatments such as surgery or radiotherapy to kill remaining cancer cells and stop it from coming back. (mahkotamedical.com)
  • This is known as neoadjuvant therapy. (mahkotamedical.com)
  • We included randomized controlled trials (RCTs) of adults with AO, AOA or anaplastic astrocytoma (AA) comparing adjuvant treatment of chemotherapy, RT, or sequential chemotherapy and RT. (cochrane.org)
  • Adjuvant chemotherapy is used after other treatments to shrink remaining cancer cells. (healthline.com)
  • Does giving chemotherapy, radiotherapy or both improve survival in people with rare (anaplastic oligodendrogliomas and oligoastrocytomas) brain tumours? (cochrane.org)
  • One study was able to demonstrate a significant survival benefit for the addition of chemotherapy to radiotherapy after surgery, compared with radiotherapy alone. (cochrane.org)
  • One of these risk-stratifying tools, the residual cancer burden (RCB) classification, quantitates the extent of residual disease in the breast and axillary lymph nodes following neoadjuvant chemotherapy and adds prognostic value to the binary assessment of pathological complete response vs. residual disease in predicting long-term survival 6 , 7 . (nature.com)
  • The addition of nivolumab to chemotherapy significantly improved event-free survival. (ascopost.com)
  • Breast cancer is a heterogeneous disease with a large variabil- survival after adjuvant polychemotherapy was 10% (from ity in clinical outcome. (lu.se)
  • Breast-conserving surgery (BCS), i.e. a partial mastectomy, followed by radiotherapy, is today a common alternative to mastectomy, when treating early breast cancer. (springer.com)
  • Traditionally, the standard of care for people with rare anaplastic oligodendrogliomas and anaplastic oligoastrocytomas (brain tumours) has been surgery followed by radiotherapy. (cochrane.org)
  • However, the benefit of adjuvant (post-surgery) chemotherapy and radiotherapy is still unclear. (cochrane.org)
  • Furthermore, in one study, these specific chromosome deletions and mutations predicted which group of participants derived benefit from the addition of chemotherapy to radiotherapy after surgery. (cochrane.org)
  • Neoadjuvant chemotherapy is the type used before surgery. (healthline.com)
  • The term neoadjuvant chemotherapy should be used to refer to chemotherapy before surgery. (healthline.com)
  • Neoadjuvant chemotherapy , which is chemotherapy before surgery, is being used increasingly more often to treat breast cancer that has spread locally. (healthline.com)
  • The addition of nivolumab to neoadjuvant chemotherapy did not increase the incidence of adverse events or impede the feasibility of surgery. (ascopost.com)
  • This is chemotherapy given to you before your main treatment, which is usually surgery or radiotherapy . (owise.uk)
  • Adjuvant chemotherapy is given after your initial treatment, such as surgery or radiotherapy. (owise.uk)
  • Chemotherapy can be used to shrink tumours to ensure less surgery and shrink cancer for a smaller area of radiotherapy. (mahkotamedical.com)
  • The goal of these response through neoadjuvant chemotherapy, policies is to establish collective guidelines to particularly usinga nthracyclines and taxanes-based increase health and quality of life through combination, surgery, radiotherapy and hormone- prevention, treatment of disease and health based therapy5. (bvsalud.org)
  • Chemotherapy (often called chemo) is a common treatment for breast cancer. (owise.uk)
  • How does chemotherapy target breast cancer cells? (owise.uk)
  • There are multiple chemotherapy drugs to treat breast cancer. (owise.uk)
  • When do you get chemotherapy for breast cancer? (owise.uk)
  • Chemotherapy can be given for both primary and secondary breast cancer. (owise.uk)
  • For primary (early-stage) breast cancer, a chemotherapy regimen combining two to three drugs is usually recommended. (owise.uk)
  • Palliative chemotherapy helps shrink cancer, improve or eliminates cancer symptoms to help you live longer. (mahkotamedical.com)
  • Standard care of adjuvant treatment for anaplastic oligodendrogliomas (AO) and anaplastic oligoastrocytomas (AOA) is not yet well defined. (cochrane.org)
  • Based on the differences in participant selection with respect to the definition of AO (two versus three high-risk anaplastic features), the inclusion of AA and sequence of treatment (RT and chemotherapy), we could not consider the results from the three RCTs for meta-analysis. (cochrane.org)
  • The trial supported the March 2022 approval of nivolumab combined with platinum-doublet chemotherapy for resectable NSCLC in the neoadjuvant setting. (ascopost.com)
  • Chemicals in chemotherapy drugs target cells that rapidly divide, such as cancer cells. (healthline.com)
  • however, these drugs work best when combined with conventional chemotherapy agents. (wjgnet.com)
  • B) Certain chemotherapy drugs interrupt the cell division process by preventing DNA replication, leading to cell death. (owise.uk)
  • Are all chemotherapy drugs the same? (owise.uk)
  • Drugs are often combined as each chemotherapy drug can affect cancer cells in a different way. (owise.uk)
  • Chemotherapy can be used as the primary or sole treatment of cancer if your type of cancer is sensitive to it. (mahkotamedical.com)
  • Potentially, the multi-agent FOLFIRINOX regimen (5-fluorouracil with leucovorin, irinotecan, and oxaliplatin) may further improve outcomes in the neoadjuvant setting for localized pancreatic cancer, but randomized studies are needed. (nih.gov)
  • Uneétude descriptive, transversale portant sur les patientes traitées en radiothérapie à l'Hôpital Général de Douala pour cancer du col de l'utérus a été réalisée d'octobre 2020 à janvier 2021.Résultats. (bvsalud.org)
  • A descriptive cross over study of women treated by radiotherapy at the Douala General Hospital from October 2020 to January 2021 was conducted. (bvsalud.org)
  • Other uses of cytostatic chemotherapy agents (including the ones mentioned below) are the treatment of autoimmune diseases such as multiple sclerosis and rheumatoid arthritis and the suppression of transplant rejections (see immunosuppression and DMARDs ). (wikidoc.org)
  • Chemotherapy , in its most general sense, refers to treatment of disease by chemicals that kill cells, specifically those of micro-organisms or cancer . (wikidoc.org)
  • RESULTS: Neoadjuvant chemotherapy consisted of a combination of platinum based agents (n = 19) with gemcitabine (n = 15) or pemetrexed (n = 4). (smw.ch)
  • The technique has been increasingly used since 1992, when a 90 % remission rate for STS treated by a combination of chemotherapy and Tumour Necrosis Factor alpha (TNFα) has been demonstrated [ 6 ]. (jcancer.org)
  • Cite this: FDA OKs Pembrolizumab for Adjuvant Treatment of NSCLC - Medscape - Jan 27, 2023. (medscape.com)
  • Consolidation chemotherapy is used to target cancer cells that are still in the body after initial treatment. (healthline.com)
  • Consolidation chemotherapy is used after initial treatment to target remaining cancer cells. (healthline.com)
  • The term induction chemotherapy is often used interchangeably with the term neoadjuvant chemotherapy, even among cancer researchers. (healthline.com)
  • The length of induction chemotherapy can vary based on the type and extent of your cancer. (healthline.com)
  • Induction chemotherapy may be used to treat people with esophageal cancer that has spread to surrounding tissues. (healthline.com)
  • Multivariable regression models adjusted for age, race/ethnicity, socioeconomic status, cancer stage, grade, neoadjuvant/adjuvant chemotherapy use, radiotherapy use, and germline BRCA1/2 mutations were used to evaluate associations between absolute lymphocyte count (ALC), BCM and OM. (sutterhealth.org)
  • The first drug used for cancer chemotherapy, however, dates back to the early 20th century, though it was not originally intended for that purpose. (wikidoc.org)
  • Commonly associated with the treatment of cancer, chemotherapy can be divided into two - cancer chemotherapy and antimicrobial chemotherapy. (mahkotamedical.com)
  • Cancer Chemotherapy. (mahkotamedical.com)
  • Whether chemotherapy is done as part of your treatment is dependent on how big it is and how far it has spread, chemotherapy is done on people with cancer for a multitude of purposes with different outcome goals. (mahkotamedical.com)
  • In all, 297 women completed a study-specific questionnaire 1 year after conventional BCS and radiotherapy. (springer.com)
  • Consolidation chemotherapy is administered after initial treatment to target cancers cells that may still be in your body. (healthline.com)
  • Il s'agissait d'une étude rétrospective descriptive d'une durée de 2 ans 3 mois allant du 1er janvier 2018 au 31 Mars 2020 portant sur 80 dossiers de malades porteurs d'hémopathies malignes et prise en charge dans le centre. (bvsalud.org)